Medicare Enrolled

Dr. Nicole Chiappetta, DO

Rheumatology · Bethlehem, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2775 SCHOENERSVILLE RD, Bethlehem, PA 18017
6108618080
In practice since 2005 (20 years)
NPI: 1275525503 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chiappetta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chiappetta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chiappetta

Dr. Nicole Chiappetta is a rheumatology specialist in Bethlehem, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chiappetta performed 86,396 Medicare services across 997 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chiappetta received a total of $3,732 from 26 pharmaceutical and/or device companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chiappetta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 16% volume in PA $3,732 industry payments

Medicare Practice Summary

Medicare Utilization ↗
86,396
Medicare services
Top 16% in PA for rheumatology
997
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,320 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
52,600 $4 $21
Tocilizumab injection (Actemra) 15,480 $5 $15
Romosozumab injection (Evenity) for osteoporosis 8,190 $8 $21
Denosumab injection (Prolia/Xgeva) 7,440 $18 $48
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
940 $26 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
410 $82 $229
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
354 $1 $7
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
263 $53 $145
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
192 $10 $65
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
86 $62 $149
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
85 $91 $285
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
78 $20 $65
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
60 $48 $148
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
53 $21 $45
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
45 $45 $600
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
37 $11 $46
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
27 $102 $275
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
27 $55 $172
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
17 $21 $85
X-ray of sacroiliac joint, 3 or more views
An X-ray imaging test that takes three or more pictures of the joint connecting the lower spine to the hip bone.
12 $22 $55
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
98.0% medium
0.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,732
Total received (2018-2024)
Avg $533/year across 7 years
Top 44% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
246
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,732 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$273
2023
$627
2022
$1,064
2021
$503
2020
$392
2019
$353
2018
$520

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$125
ABBVIE INC.
$125
SCILEX PHARMACEUTICALS INC.
$23
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,053
UCB, Inc.
$566
Celgene Corporation
$419
AbbVie Inc.
$353
ABBVIE INC.
$283
Janssen Biotech, Inc.
$235
PFIZER INC.
$194
AstraZeneca Pharmaceuticals LP
$133
GlaxoSmithKline, LLC.
$61
Actelion Pharmaceuticals US, Inc.
$52
Lilly USA, LLC
$51
Genentech USA, Inc.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$41
Radius Health, Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Sobi, Inc
$25
SCILEX PHARMACEUTICALS INC.
$23
Mallinckrodt LLC
$23
Alexion Pharmaceuticals, Inc.
$18
Novartis Pharmaceuticals Corporation
$18
Horizon Therapeutics plc
$15
AbbVie, Inc.
$15
Orthogenrx Inc.
$13
Antares Pharma, Inc.
$13
Cumberland Pharmaceuticals, Inc.
$12
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 54.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · BENLYSTA · COSENTYX · Cimzia · EVENITY · Enbrel · FORTEO · GenVisc 850 · HUMIRA · Humira · IBRANCE · KINERET · KRYSTEXXA · LYRICA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · Otrexup · REDITREX · REMICADE · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Bethlehem?
Compare rheumatologists in the Bethlehem area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
21
Per 100K population
6.6
County median income
$86,687
Nearest hospital
ST LUKES HOSPITAL BETHLEHEM
5.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chiappetta is a mixed practice specialist, with above-average Medicare volume (top 16% in PA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chiappetta experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Chiappetta performed 52,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chiappetta receive payments from pharmaceutical companies?
Yes. Dr. Chiappetta received a total of $3,732 from 26 companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chiappetta's costs compare to other rheumatologists in Bethlehem?
Dr. Chiappetta's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chiappetta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →